DrugRepV Browse Page

DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Northern blot are 6

DrugRepV_ID	Antiviral Name	Drug type	Primary Indication	Secondary Indication	Strain	Pathways	Assay	Activity	Clinical Status	References
DrugRepV_3066	Abamectin	NA	Helmintic infection	Chikungunya virus	CHIKV-Rluc	NA	Northern blot	Decrease	Terminated	26752081
DrugRepV_3067	Ivermectin	Antiparasitic products, Insectisides and Repellents	Intestinal strongyloidiasis | Onchocerciasis	Chikungunya virus	CHIKV-Rluc	NA	Northern blot	Decrease	Approved, Investigational, Vet approved	26752081
DrugRepV_6022	Saracatinib	Anticancer	Cancer	Dengue virus	New Guinea C		Northern blot	Decrease (60 AU (Arbitrary units))	Investigational	23616652
DrugRepV_6023	Dasatinib	Antineoplastic and Immunomodulating Agents	Cancer	Dengue virus	New Guinea C		Northern blot	Decrease (65 AU (Arbitrary units))	Approved	23616652
DrugRepV_6024	Saracatinib	Anticancer	Cancer	Dengue virus	New Guinea C		Northern blot	Decrease (65 AU (Arbitrary units))	Investigational	23616652
DrugRepV_6025	Dasatinib	Antineoplastic and Immunomodulating Agents	Cancer	Dengue virus	New Guinea C		Northern blot	Decrease (75 AU (Arbitrary units))	Approved	23616652